|
Volume 270,
Number 41,
Issue of October 13, 1995 pp. 24482-24488
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Inhibition of
ADP-induced Platelet Responses by Covalent Modification of Aggregin, a
Putative ADP Receptor, by 8-(4-Bromo-2,3-dioxobutylthio)ADP
(Received for publication, May 15, 1995; and in revised form, July
18, 1995)
Rajinder N.
Puri
,
Ajay
Kumar
,
Haiying
Chen
,
Roberta
F.
Colman
,
Robert W.
Colman
ADP is an important platelet agonist which initiates platelet
shape change, aggregation, exposure of fibrinogen receptors, and
calcium mobilization. Because of the limitations of previously used
affinity analogs and photolabeling studies as well as controversies
surrounding the identity of an ADP receptor on platelets, we have used
an affinity label capable of alkylating a putative exofacial receptor
on platelets. We now report that
8-(4-bromo-2,3-dioxobutylthio)adenosine-5`-diphosphate (8-BDB-TADP),
which is an analog of the natural ligand ADP, blocked ADP-induced
platelet shape change, aggregation, exposure of fibrinogen-binding
sites, secretion, and calcium mobilization. Following modification by
8-BDB-TADP, the rates of aggregation of platelets induced by thrombin,
a calcium ionophore (A23187) or a stimulator of protein kinase C
(phorbol myristate acetate) were minimally affected. However, the
8-BDB-TADP-modified platelets exhibited decreased rates of aggregation
in response to ADP, as well as collagen and a thromboxane mimetic
(U46619), both of which partially require ADP. Autoradiograms of the
gels obtained by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis of solubilized platelets modified by either
[ - P]8-BDB-TADP, or 8-BDB-TADP and
NaB[ H] showed the presence of a
single radiolabeled protein band at 100 kDa. The intensity of this band
was reduced when platelets were preincubated with ADP, ATP, and
8-bromo-ADP prior to labeling by the radioactive 8-BDB-TADP. The
results show that 8-BDB-TADP selectively and covalently labeled
aggregin (100 kDa), a putative ADP receptor, resulting in a loss of
ADP-induced platelet responses.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. M. B. Francischetti, J. M. C. Ribeiro, D. Champagne, and J. Andersen
Purification, Cloning, Expression, and Mechanism of Action of a Novel Platelet Aggregation Inhibitor from the Salivary Gland of the Blood-sucking Bug, Rhodnius prolixus
J. Biol. Chem.,
April 21, 2000;
275(17):
12639 - 12650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. E. Clifford, K. Parker, B. D. Humphreys, S. B. Kertesy, and G. R. Dubyak
The P2X1 Receptor, an Adenosine Triphosphate-Gated Cation Channel, Is Expressed in Human Platelets but not in Human Blood Leukocytes
Blood,
May 1, 1998;
91(9):
3172 - 3181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Greco
Functional Expression of a P2T ADP Receptor in Xenopus Oocytes Injected With Megakaryocyte (CMK 11-5) RNA
Arterioscler. Thromb. Vasc. Biol.,
April 1, 1997;
17(4):
769 - 777.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|